Takeda Pharmaceutical
TAK
#491
Rank
C$65.57 B
Marketcap
C$19.70
Share price
0.28%
Change (1 day)
3.70%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total debt

Total debt on the balance sheet as of September 2025 : C$43.49 Billion

According to Takeda Pharmaceutical's latest financial reports the company's total debt is C$43.49 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Takeda Pharmaceutical - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2025-03-31C$43.34 B0.19%
2024-03-31C$43.26 B-2.7%
2023-03-31C$44.46 B-0.33%
2022-03-31C$44.60 B-15.18%
2021-03-31C$52.58 B-21.15%
2020-03-31C$66.69 B-3.55%
2019-03-31C$69.15 B478.53%
2018-03-31C$11.95 B-12.71%
2017-03-31C$13.69 B54.34%
2016-03-31C$8.87 B15.07%
2015-03-31C$7.71 B-16.27%
2014-03-31C$9.20 B46.03%
2013-03-31C$6.30 B-3.51%
2012-03-31C$6.53 B2638.61%
2011-03-31C$0.23 B18.13%
2010-03-31C$0.20 B-19.83%
2009-03-31C$0.25 B656.1%
2008-03-31C$33.32 M-70.81%
2007-03-31C$0.11 B-9.15%
2006-03-31C$0.12 B-39.72%
2005-03-31C$0.20 B13.05%
2004-03-31C$0.18 B17.83%
2003-03-31C$0.15 B-16.31%
2002-03-31C$0.18 B-6.74%
2001-03-31C$0.20 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
C$63.45 B 45.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$35.37 B-18.66%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
C$84.31 B 93.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$44.37 B 2.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
C$0.15 B-99.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
C$0.91 B-97.90%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
C$75.63 B 73.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$33.06 B-23.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$57.33 B 31.82%๐Ÿ‡บ๐Ÿ‡ธ USA